Protein corona of airborne nanoscale PM2.5 induces aberrant proliferation of human lung fibroblasts based on a 3D organotypic culture.
Study subjects
Primary human lung fibroblasts in a 3D fibrin-hydrogel organotypic culture
Oxidative stress assays
ROS fluorescence in 3D-cultured HLFs across an NPM-protein corona dose series
Intracellular ROS labelled with DCFH-DA in 3D-cultured HLFs exposed for three days to the NPM-protein corona at 5, 10 and 20 ug/ml NPM. ROS increased positively with NPM concentration. Fluorescence intensity is reported only in Fig. 5A with images in Fig. 5F-H, so no numeric value is recorded. Significance versus control was marked *P < 0.05, **P < 0.01 in the figure legend without per-group attribution in the text.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc5 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
5 microgram per milliliter | 3 day |
| NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc10 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
10 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-dose-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition, HLF medium alone. Figure-only values; none recorded. |
| treated | NPC 5 ug/ml NPM 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-dose-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5 |
Lowest dose of the dose series; ROS increased relative to control. Figure-only values; none recorded. |
| treated | NPC 10 ug/ml NPM 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-dose-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10 |
Middle dose of the dose series. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-dose-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
Highest dose of the dose series; largest ROS increase. Figure-only values; none recorded. |
Evidence
shows a positive ROS increase in relation to the NPM concentration.
States exactly what this assay records: ROS fluorescence in the 3D-cultured HLFs rose with the NPM concentration of the protein corona.
Taken together, these results demonstrate that the NPM-protein corona is expected to result in a limited increase in ROS levels.
The authors' summary of the magnitude of the ROS response recorded here - an increase, but a limited one.
ROS fluorescence in 3D-cultured HLFs with vitamin C or TGF-beta1
ROS labelled with DCFH-DA in 3D-cultured HLFs exposed for three days to the NPM-protein corona (20 ug/ml NPM), to the same corona co-treated with vitamin C 0.1 mg/ml, or to TGF-beta1 2 ng/ml. Vitamin C repressed ROS generation and TGF-beta1 promoted it, reproducing the corona response. Values reported only in Fig. 5B with images in Fig. 5C-E; none recorded.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days EXPOSURE:li2018-3dhlf-npc20-vc |
ascorbic acid CHEBI:22652 |
0.1 milligram per milliliter | 3 day |
| TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator) EXPOSURE:li2018-3dhlf-tgfb1 |
— | 2 nanogram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-modulators-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition, HLF medium alone. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-modulators-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
Corona group against which the modulators were compared; ROS increased. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-modulators-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc |
ROS generation effectively repressed relative to the corona group. Figure-only values; none recorded. |
| treated | TGF-beta1 2 ng/ml 3D-HLFs - ROS fluorescence OX:li2018-3dhlf-ros-modulators-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1 |
Positive comparator; TGF-beta1 promoted ROS. Figure-only values; none recorded. |
Evidence
An antioxidant (vitamin C) effectively repressed ROS generation
States the vitamin C result this assay records: co-treatment suppressed the corona-driven ROS increase, which is the antioxidant control on the oxidative stress event.
TGF-β1 promoted ROS, as has been reported in the literature
States the positive-comparator result this assay records: TGF-beta1 raised ROS in the same 3D system.
GSH fluorescence in 3D-cultured HLFs across the NPM-protein corona dose series and with vitamin C or TGF-beta1
Intracellular glutathione labelled with ThioGlo-1 in 3D-cultured HLFs after three days. GSH depletion was detected in every NPM-protein corona group (5, 10 and 20 ug/ml NPM) and in the TGF-beta1 group, accompanying the ROS rise; vitamin C co-treatment suppressed the depletion. Values reported only in Fig. 6A-B with images in Fig. 6C-H; none recorded.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc5 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
5 microgram per milliliter | 3 day |
| NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc10 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
10 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days EXPOSURE:li2018-3dhlf-npc20-vc |
ascorbic acid CHEBI:22652 |
0.1 milligram per milliliter | 3 day |
| TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator) EXPOSURE:li2018-3dhlf-tgfb1 |
— | 2 nanogram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - GSH fluorescence OX:li2018-3dhlf-gsh-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition, HLF medium alone. Figure-only values; none recorded. |
| treated | NPC 5 ug/ml NPM 3D-HLFs - GSH fluorescence OX:li2018-3dhlf-gsh-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5 |
GSH depletion detected. Figure-only values; none recorded. |
| treated | NPC 10 ug/ml NPM 3D-HLFs - GSH fluorescence OX:li2018-3dhlf-gsh-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10 |
GSH depletion detected. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - GSH fluorescence OX:li2018-3dhlf-gsh-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
GSH depletion detected. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - GSH fluorescence OX:li2018-3dhlf-gsh-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc |
GSH depletion effectively suppressed relative to the corona group. Figure-only values; none recorded. |
| treated | TGF-beta1 2 ng/ml 3D-HLFs - GSH fluorescence OX:li2018-3dhlf-gsh-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1 |
Positive comparator; GSH depletion detected. Figure-only values; none recorded. |
Evidence
GSH depletion was detected in all groups of NPM-protein corona preparations and TGF-β1
States exactly what this assay records: glutathione was depleted in every corona dose group and in the TGF-beta1 comparator.
Vitamin C effectively suppressed GSH depletion
States the antioxidant control result this assay records: vitamin C prevented the corona-driven GSH depletion.
Intracellular MDA in 3D-cultured HLFs across the NPM-protein corona dose series and with vitamin C or TGF-beta1
Malondialdehyde, a lipid peroxidation end product, measured by ELISA after three days. Despite the ROS rise and GSH depletion, the NPM-protein corona induced no MDA increase at any dose, and neither vitamin C nor TGF-beta1 changed MDA. This negative result is the basis for the authors' conclusion that the corona produces a limited ROS increase without oxidative damage. Values reported only in Fig. 7A-B; none recorded.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc5 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
5 microgram per milliliter | 3 day |
| NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc10 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
10 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days EXPOSURE:li2018-3dhlf-npc20-vc |
ascorbic acid CHEBI:22652 |
0.1 milligram per milliliter | 3 day |
| TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator) EXPOSURE:li2018-3dhlf-tgfb1 |
— | 2 nanogram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - intracellular MDA OX:li2018-3dhlf-mda-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition. Figure-only values; none recorded. |
| treated | NPC 5 ug/ml NPM 3D-HLFs - intracellular MDA OX:li2018-3dhlf-mda-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5 |
No MDA increase versus control. Figure-only values; none recorded. |
| treated | NPC 10 ug/ml NPM 3D-HLFs - intracellular MDA OX:li2018-3dhlf-mda-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10 |
No MDA increase versus control. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - intracellular MDA OX:li2018-3dhlf-mda-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
No MDA increase versus control even at the highest dose. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - intracellular MDA OX:li2018-3dhlf-mda-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc |
No change in MDA. Figure-only values; none recorded. |
| treated | TGF-beta1 2 ng/ml 3D-HLFs - intracellular MDA OX:li2018-3dhlf-mda-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1 |
No change in MDA. Figure-only values; none recorded. |
Evidence
The NPM-protein corona stimulated ROS generation but induced no MDA increase
Recorded as REFUTE because this measurement argues against membrane lipid-peroxidation damage as part of the oxidative stress event: MDA did not rise even though ROS did.
Moreover, the antioxidant (vitamin C) and TGF-β1 showed no change in MDA or 8-OH-dG
The modulator arms of this assay were also flat, so no treatment in the study produced a detectable lipid peroxidation signal.
However, ROS generation induced no oxidative damage.
The authors' own reading of this and the 8-OH-dG assay: the ROS increase did not translate into oxidative damage.
Intracellular 8-OH-dG in 3D-cultured HLFs across the NPM-protein corona dose series and with vitamin C or TGF-beta1
8-hydroxydeoxyguanosine, the most commonly measured marker of oxidative DNA damage, measured by ELISA after three days. The NPM-protein corona induced no variation in 8-OH-dG at any dose, and neither vitamin C nor TGF-beta1 changed it. Values reported only in Fig. 7C-D; none recorded.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc5 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
5 microgram per milliliter | 3 day |
| NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc10 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
10 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days EXPOSURE:li2018-3dhlf-npc20-vc |
ascorbic acid CHEBI:22652 |
0.1 milligram per milliliter | 3 day |
| TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator) EXPOSURE:li2018-3dhlf-tgfb1 |
— | 2 nanogram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - intracellular 8-OH-dG OX:li2018-3dhlf-8ohdg-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition. Figure-only values; none recorded. |
| treated | NPC 5 ug/ml NPM 3D-HLFs - intracellular 8-OH-dG OX:li2018-3dhlf-8ohdg-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5 |
No variation versus control. Figure-only values; none recorded. |
| treated | NPC 10 ug/ml NPM 3D-HLFs - intracellular 8-OH-dG OX:li2018-3dhlf-8ohdg-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10 |
No variation versus control. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - intracellular 8-OH-dG OX:li2018-3dhlf-8ohdg-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
No variation versus control even at the highest dose. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - intracellular 8-OH-dG OX:li2018-3dhlf-8ohdg-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc |
No change in 8-OH-dG. Figure-only values; none recorded. |
| treated | TGF-beta1 2 ng/ml 3D-HLFs - intracellular 8-OH-dG OX:li2018-3dhlf-8ohdg-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1 |
No change in 8-OH-dG. Figure-only values; none recorded. |
Evidence
The NPM-protein corona also induced no variation in 8-OH-dG levels in the 3D-cultured HLFs
Recorded as REFUTE because this measurement argues against oxidative DNA damage as part of the oxidative stress event: 8-OH-dG was unchanged while ROS rose.
Moreover, the antioxidant (vitamin C) and TGF-β1 showed no change in MDA or 8-OH-dG
The modulator arms of this assay were flat as well, so no treatment produced a detectable oxidative DNA damage signal.
Gene expression assays
Alpha-SMA expression in 3D-cultured HLFs across an NPM-protein corona dose series
Alpha-smooth muscle actin immunofluorescence in 3D-cultured HLFs after three days of exposure to the NPM-protein corona at 5, 10 and 20 ug/ml NPM. The corona stimulated HLFs to express alpha-SMA and expression was positively correlated with the NPM exposure concentration. Alpha-SMA is a key protein of activated, not quiescent, fibroblasts and a fibrosis marker, so this is the proliferation pathway the authors propose. Fluorescence intensity reported only in Fig. 8A with images in Fig. 8F-H; no numeric value recorded.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc5 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
5 microgram per milliliter | 3 day |
| NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc10 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
10 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-dose-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition, HLF medium alone. Figure-only values; none recorded. |
| treated | NPC 5 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-dose-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5 |
Lowest dose; alpha-SMA raised versus control. Figure-only values; none recorded. |
| treated | NPC 10 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-dose-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10 |
Middle dose of the positively correlated series. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-dose-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
Highest dose; greatest alpha-SMA expression. Figure-only values; none recorded. |
Evidence
The results demonstrated that the NPM-protein corona stimulated HLFs to express α-SMA.
States the core result this assay records: the NPM-protein corona induced alpha-SMA expression in the 3D-cultured HLFs.
α-SMA expression was positively correlated with the NPM exposure concentration
States the dose-response this assay's three corona groups record.
α-SMA is a key protein expressed by activated HLFs but not by quiescent fibroblasts.
Establishes why alpha-SMA induction is read as fibroblast activation and therefore informs the proliferation key event.
Alpha-SMA expression in 3D-cultured HLFs with vitamin C or TGF-beta1
Alpha-SMA immunofluorescence in 3D-cultured HLFs after three days of exposure to the NPM-protein corona (20 ug/ml NPM), the same corona co-treated with vitamin C 0.1 mg/ml, or TGF-beta1 2 ng/ml. Vitamin C repressed alpha-SMA secretion, tying the induction to the ROS it also suppressed; TGF-beta1 promoted alpha-SMA, reproducing the corona effect. Values reported only in Fig. 8B with images in Fig. 8C-E; none recorded.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Control, HLF medium alone in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-control |
— | — | 3 day |
| NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days EXPOSURE:li2018-3dhlf-npc20 |
ultrafine respirable suspended particulate matter ENVO:01000416 |
20 microgram per milliliter | 3 day |
| NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days EXPOSURE:li2018-3dhlf-npc20-vc |
ascorbic acid CHEBI:22652 |
0.1 milligram per milliliter | 3 day |
| TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator) EXPOSURE:li2018-3dhlf-tgfb1 |
— | 2 nanogram per milliliter | 3 day |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Control 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-modulators-output-control · under EXPOSURE:li2018-3dhlf-control |
Reference condition. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-modulators-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20 |
Corona group against which the modulators were compared. Figure-only values; none recorded. |
| treated | NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-modulators-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc |
Alpha-SMA secretion effectively repressed relative to the corona group. Figure-only values; none recorded. |
| treated | TGF-beta1 2 ng/ml 3D-HLFs - alpha-SMA fluorescence GE:li2018-3dhlf-asma-modulators-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1 |
Positive comparator; TGF-beta1 promoted alpha-SMA expression. Figure-only values; none recorded. |
Evidence
Vitamin C effectively repressed the secretion of α-SMA
States the antioxidant-arm result this assay records, which is the authors' evidence that alpha-SMA induction is ROS-dependent.
TGF-β1 promoted α-SMA expression
States the positive-comparator result this assay records: TGF-beta1 raised alpha-SMA in the same 3D system.
Key events
Increased oxidative stress
Taken together, these results demonstrate that the NPM-protein corona is expected to result in a limited increase in ROS levels.
The paper's own characterisation of the oxidative stress event it induced: a real but limited rise in ROS, accompanied by GSH depletion and no damage markers.
Increased cell proliferation
The protein corona is believed to mitigate NPM cytotoxicity and further stimulate aberrant HLF proliferation.
The paper's conclusion naming the proliferation event, and noting that the protein coat is what makes it possible by blunting the cytotoxicity of naked NPM.
The results demonstrated that the NPM-protein corona potentially promoted the cell growth of 3D-cultured HLFs.
The MTT result establishing that proliferation increased in the exposed 3D cultures.
Key-event relationships
Increased oxidative stress leads to increased cell proliferation in 3D-cultured human lung fibroblasts
Dose-response by MTT after three days of exposure in the 3D fibrin construct: cell viabilities of 103%, 109% and 113% of control at NPM-protein corona concentrations of 5, 10 and 20 ug/ml NPM, with the 20 ug/ml group significant versus control at p < 0.01. The specificity controls were flat: naked NPM at 20 ug/ml gave 104% and pure serum 105%, so neither component alone reproduced the effect. Vitamin C co-treatment lowered viability relative to the 20 ug/ml corona group, and TGF-beta1 2 ng/ml reproduced the whole response. No numeric values are available for the intervening ROS or alpha-SMA steps, which are reported as fluorescence bar charts only, so the quantitative chain stops at the proliferation endpoint.
ROS, as signalling molecules, play an important role in mediating α-SMA upregulation.
The mechanistic step joining the two key events: the ROS increase acts as a signal that upregulates alpha-SMA.
ROS are signal molecules that stimulate cell proliferation without inducing oxidative damage.
States the relationship directly, and why it is a signalling edge rather than a damage edge - the damage markers MDA and 8-OH-dG did not move.
the addition of an antioxidant was shown to diminish the proliferation efficiency of NPM-protein corona stimulation
The interventional evidence for this edge: blocking the upstream oxidative stress with vitamin C reduced the downstream proliferation.
This suggests that oxidative stress is associated with HLF proliferation.
The authors' own statement of the relationship drawn from the antioxidant experiment.
ROS-activated alpha-smooth muscle actin (α-SMA) is considered to be one of the proliferation pathways.
The abstract's framing of the pathway, naming ROS-activated alpha-SMA as the route to proliferation.
Nanoscale airborne particles could form a protein corona in the body and initiate HLF proliferation by ROS-mediated α-SMA upregulation, which may further result in pulmonary fibrosis.
The full proposed chain, including the hedged extension to pulmonary fibrosis that this extraction deliberately does not record as a key event.
Cell numbers increased in a dose-dependent manner
The dose-dependence of the downstream event, which parallels the dose-dependence of the upstream ROS rise and of alpha-SMA.
The cell viabilities were 103%, 109% and 113%, respectively.
The numeric dose-response recorded in this relationship's description, for the corona at 5, 10 and 20 ug/ml NPM.
significantly promoted an increase in HLFs
The significance of the highest corona dose versus control for the downstream proliferation event.
The cell viabilities were 105% and 104%, respectively
The specificity controls - pure serum and naked NPM - neither of which reproduced the proliferation, so the corona complex is what drives the edge.
Cell viability declined compared to that with the NPM-protein corona
The vitamin C arm of the MTT assay, the quantitative counterpart of the antioxidant evidence for this edge.
TGF-β1 was also shown to promote HLF proliferation in the 3D model
The positive comparator closing the loop: TGF-beta1 raised ROS, depleted GSH, raised alpha-SMA and raised proliferation, matching the corona response at every step of this edge.
Based on a 3D organotypic cell culture, the protein corona was shown to mitigate NPM cytotoxicity and further stimulate the proliferation of human lung fibroblasts (HLFs).
The abstract's statement of the model system and the overall outcome this relationship describes.
Consequently, the final cell exposure concentrations of NPM were 5, 10 and 20 μg/ml.
The Methods statement fixing the three corona doses used throughout; the earlier 25/50/100 ug/ml figures are pre-dilution stock concentrations, not exposures.
The cell exposure concentrations of TGF-β1 and vitamin C in the 3D systems were 2 ng/ml and 0.1 mg/ml, respectively.
The Methods statement fixing the comparator and antioxidant doses recorded on the exposure conditions above.
Following exposure to the different test groups, HLFs were cultured in the 3D culture systems for three days.
The Methods statement fixing the three-day exposure duration recorded on every exposure condition above.
Cells were suspended at 2 × 106 cells/ml and mixed with the NPC solutions.
The seeding density of the 3D construct, recorded in the culture protocol.
Cell proliferation was measured using an MTT kit (Nanjing Jiancheng, China).
The method behind the viability percentages in this relationship's description, recorded in the MTT protocol.
To verify the biological function of the protein corona, pure serum and NPM
Names the two specificity-control arms whose viabilities are quoted above, confirming they were run to test the corona's own contribution.
Protocols
3D organotypic fibrin-hydrogel culture of human lung fibroblasts
Human lung fibroblasts were suspended at 2 x 10^6 cells/ml, mixed with the exposure solution, fibrinogen (10 mg/ml) and thrombin (100 U/ml) in a ratio of 60:20:19:1 on ice, and seeded as 15 ul aliquots in a microfluidic chip (AIM Biotech, Singapore) for imaging or 50 ul aliquots in a 96-well plate for quantitative assays. Gelation ran 1 h at 37 C, after which the construct was filled with HLF culture medium, replaced daily, and cultured for three days. Fibrinogen was dissolved in FBS-free HLF medium; thrombin in DPBS containing 0.1% BSA.
Equipment: Microfluidic chip (AIM Biotech, Singapore); Fibrinogen (Sigma) and thrombin (Sigma); Confocal microscope (Olympus IX81)
MTT assay for cell proliferation of 3D-cultured HLFs
After three days of exposure the cell medium was removed by pipetting and 100 ul of gel dissociation saline solution (Biovision) was added. Mixtures were incubated at room temperature for 5-10 min and pipetted with a 1 ml tip until the fibrin matrix dissolved, then centrifuged at 1,000 x g for 5 min at 4 C and the supernatant removed. Cell proliferation was measured with an MTT kit (Nanjing Jiancheng, China) and reported as cell viability relative to the untreated control.
Equipment: Microplate reader; MTT assay kit (Nanjing Jiancheng); Gel dissociation saline solution (Biovision)
DCFH-DA fluorescence detection of intracellular ROS in 3D-cultured HLFs
Intracellular reactive oxygen species were labelled with DCFH-DA (Merck KGaA, Germany). Images of fluorochrome-labelled ROS in 3D-cultured HLFs were captured on a confocal microscope (Olympus IX81) at x10 magnification and processed with Imaris software. For quantification, 3D-cultured HLFs on cell plates were released from the fibrin matrix with gel dissociation saline solution and ROS fluorescence intensity was read on a fluorescence reader (FLx800; BioTek Instruments).
Equipment: Confocal microscope (Olympus IX81); Fluorescence reader (FLx800, BioTek Instruments); DCFH-DA probe (Merck KGaA)
ThioGlo-1 fluorescence detection of intracellular GSH in 3D-cultured HLFs
Intracellular glutathione was labelled with ThioGlo(TM)-1 (Merck KGaA, Germany). Images of fluorochrome-labelled GSH in 3D-cultured HLFs were captured on a confocal microscope (Olympus IX81) at x10 magnification. GSH fluorescence intensity was quantified on a fluorescence reader (FLx800; BioTek Instruments) after the cells were released from the fibrin matrix.
Equipment: Confocal microscope (Olympus IX81); Fluorescence reader (FLx800, BioTek Instruments); ThioGlo-1 probe (Merck KGaA)
ELISA quantification of MDA and 8-OHdG in 3D-cultured HLFs
Concentrations of malondialdehyde (MDA, a lipid peroxidation end product) and 8-hydroxydeoxyguanosine (8-OHdG, a marker of oxidative DNA damage) were measured with ELISA kits according to the manufacturer's instructions (Nanjing Jiancheng, China), on 3D-cultured HLFs recovered from the fibrin matrix by gel dissociation and centrifugation.
Equipment: Microplate reader; MDA and 8-OHdG ELISA kits (Nanjing Jiancheng)
Alpha-SMA immunofluorescence in 3D-cultured HLFs
Alpha-smooth muscle actin was detected with a fluorescent anti-alpha-SMA agent (Abcam, USA) in HLFs cultured in the microfluidic chip. Nuclei were counterstained with DAPI (Invitrogen) and live cells labelled with an Invitrogen live-cell dye. 3D fluorescence images were captured on a confocal microscope (Olympus IX81) at x10 magnification and processed with Imaris software; the fluorescence intensity of alpha-SMA expression was analysed with ImageJ software.
Equipment: Confocal microscope (Olympus IX81); Imaris software (Bitplane Scientific Software); ImageJ software